Market Value313,687,000
Total Holdings61
File Date2021-11-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
SLRX / Salarius Pharmaceuticals, Inc.
CRTX / Cortexyme Inc Put
LOGC / ContextLogic Holdings Inc.
CBAY / CymaBay Therapeutics, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
MBRX / Moleculin Biotech, Inc.
PRQR / ProQR Therapeutics N.V.
AGLE / Aeglea BioTherapeutics Inc
EPIX / ESSA Pharma Inc.
AMGN / Amgen Inc.
SYRS / Syros Pharmaceuticals, Inc.
CAH / Cardinal Health, Inc.
MGNX / MacroGenics, Inc.
CBIO / Crescent Biopharma, Inc.
AVAH / Aveanna Healthcare Holdings Inc.
IDYA / IDEAYA Biosciences, Inc.
CNC / Centene Corporation
CHRS / Coherus Oncology, Inc.
HLF / Herbalife Ltd.
LPTX / Leap Therapeutics, Inc.
ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
SEER / Seer, Inc.
CVRX / CVRx, Inc.
HZNP / Horizon Therapeutics Plc
BCEL / Atreca, Inc.
CHAQ.U / Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of , and one
ASGN / ASGN Incorporated
FULC / Fulcrum Therapeutics, Inc.
GOSS / Gossamer Bio, Inc.
KURA / Kura Oncology, Inc.
MEIP / MEI Pharma, Inc.
NARI / Inari Medical, Inc.
RDUS / Radius Recycling, Inc.
EVLO / Evelo Biosciences, Inc. Put
/ PHILLIPS EDISON & CO INC
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock) Put
RCOR.WS / Renovacor, Inc. Warrants, enti Warrants, entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11.50 per whole share
SOLY / Soliton Inc
CCRN / Cross Country Healthcare, Inc.
SPRB / Spruce Biosciences, Inc.
MRSN / Mersana Therapeutics, Inc.
HRC / Hill-Rom Holdings Inc
SYNH / Syneos Health Inc - Class A
NLTX / Neoleukin Therapeutics, Inc.
AFMD / Affimed N.V.
HCA / HCA Healthcare, Inc.
MEOBF / Mesoblast Limited Put
GILD / Gilead Sciences, Inc.
CYCC / Cyclacel Pharmaceuticals, Inc.
UTHR / United Therapeutics Corporation
VINC / Vincerx Pharma, Inc.
CMAX / CareMax, Inc.
GLD / SPDR Gold Trust
HQY / HealthEquity, Inc.
DTIL / Precision BioSciences, Inc.
ALBO / Albireo Pharma Inc
CMAXW / CareMax Inc - Warrants (08/06/2026)
ITGR / Integer Holdings Corporation
AMN / AMN Healthcare Services, Inc.
ARNA / Arena Pharmaceuticals Inc
VRTX / Vertex Pharmaceuticals Incorporated
AYLA / Ayala Pharmaceuticals Inc
RUBY / Rubius Therapeutics, Inc.
NTUS / Natus Medical Inc
CI / The Cigna Group
SRRA / Sierra Oncology Inc
MCK / McKesson Corporation
UHS / Universal Health Services, Inc.
CHAQ / Chardan Healthcare Acquisition 2 Corp
NBSE / NeuBase Therapeutics, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
HSAQ / Health Sciences Acquisitions Corp 2
EUCRU / Eucrates Biomedical Acquisition Corp
XFOR / X4 Pharmaceuticals, Inc.
ARDX / Ardelyx, Inc.
CRIS / Curis, Inc.
RIGL / Rigel Pharmaceuticals, Inc.
MRK / Merck & Co., Inc.
HUMAW / Humacyte, Inc. - Equity Warrant
FUSN / Fusion Pharmaceuticals Inc.
PTGX / Protagonist Therapeutics, Inc.
VKTX / Viking Therapeutics, Inc.
NYXH / Nyxoah SA
TVTX / Travere Therapeutics, Inc.